Oxaliplatin (Mylan Institutional LLC)
Welcome to the PulseAid listing for the Oxaliplatin drug offered from Mylan Institutional LLC. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Institutional LLC |
NON-PROPRIETARY NAME: | Oxaliplatin |
SUBSTANCE NAME: | OXALIPLATIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-08-09 |
END MARKETING DATE: | 0000-00-00 |
Oxaliplatin HUMAN PRESCRIPTION DRUG Details:
Item Description | Oxaliplatin from Mylan Institutional LLC |
LABELER NAME: | Mylan Institutional LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/mL) |
START MARKETING DATE: | 2012-08-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 67457-442_b3e97a3f-d9f3-48c0-bdbd-d26a5e2b7ba0 |
PRODUCT NDC: | 67457-442 |
APPLICATION NUMBER: | ANDA091358 |
Other OXALIPLATIN Pharmaceutical Manufacturers / Labelers: